Tchaikapharma Highquality Medicines AD (XBUL:THQM) ROCE %

: 1.51% (As of Sep. 2023)

View and export this data going back to 2012. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tchaikapharma Highquality Medicines AD's annualized ROCE % for the quarter that ended in Sep. 2023 was 1.51%.

Tchaikapharma Highquality Medicines AD ROCE % Historical Data

The historical data trend for Tchaikapharma Highquality Medicines AD's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tchaikapharma Highquality Medicines AD Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

14.17

3.26

0.86

1.82

3.31

Tchaikapharma Highquality Medicines AD Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															2.67	-0.67	8.34	9.50	1.51

Tchaikapharma Highquality Medicines AD ROCE % Calculation

Tchaikapharma Highquality Medicines AD's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	3.413	/	( ( (117.457 - 15.74)	+	(119.861 - 15.644) )	/ 2 )
	=	3.413	/	( (101.717	+	104.217)	/ 2 )
	=	3.413	/	102.967
	=	3.31 %

Tchaikapharma Highquality Medicines AD's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	1.632	/	( ( (121.666 - 13.398)	+	(121.882 - 13.799) )	/ 2 )
	=	1.632	/	( ( 108.268	+	108.083 )	/ 2 )
	=	1.632	/	108.1755
	=	1.51 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Tchaikapharma Highquality Medicines AD (XBUL:THQM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tchaikapharma Highquality Medicines AD ROCE % Related Terms

Thank you for viewing the detailed overview of Tchaikapharma Highquality Medicines AD's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 G. M. Dimitrov Boulevard, Sofia, BGR, 1172

Website

https://www.tchaikapharma.com

Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. It manufactures medicines for cancer, heart diseases, respiratory problems, and neurological diseases, among others.

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Headlines

No Headlines